{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Morphine+sulphate&page=3", "query": { "intervention": "Morphine sulphate", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 775, "total_pages": 78, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Morphine+sulphate&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Morphine+sulphate&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-06T06:11:15.590Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06192589", "title": "Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cannabidiol", "Drug Induced Liver Injury", "Drug Interaction" ], "interventions": [ { "name": "Cannabidiol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Citalopram", "type": "DRUG" }, { "name": "Morphine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Food and Drug Administration (FDA)", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 241, "start_date": "2024-02-08", "completion_date": "2024-09-06", "has_results": true, "last_update_posted_date": "2025-07-31", "last_synced_at": "2026-10-06T06:11:15.590Z", "location_count": 1, "location_summary": "West Bend, Wisconsin", "locations": [ { "city": "West Bend", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT06192589" }, { "nct_id": "NCT03475862", "title": "Nasal Human Abuse Potential of PTI-821", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Opioid Abuse Nondependent" ], "interventions": [ { "name": "PTI-821 capsule Manipulated", "type": "DRUG" }, { "name": "PTI-821 Non-manipulated", "type": "DRUG" }, { "name": "OxyContin", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Oxycodone", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pain Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 38, "start_date": "2017-05-15", "completion_date": "2017-12-15", "has_results": false, "last_update_posted_date": "2018-03-23", "last_synced_at": "2026-10-06T06:11:15.590Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT03475862" }, { "nct_id": "NCT01832402", "title": "Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Advanced Cancers" ], "interventions": [ { "name": "Fentanyl Pectin Nasal Spray", "type": "DRUG" }, { "name": "Placebo Nasal Spray", "type": "DRUG" }, { "name": "Walk Test", "type": "OTHER" }, { "name": "Questionnaires", "type": "BEHAVIORAL" }, { "name": "Mental Ability Tests", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "OTHER", "BEHAVIORAL" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2013-06-11", "completion_date": "2019-11-25", "has_results": true, "last_update_posted_date": "2023-06-08", "last_synced_at": "2026-10-06T06:11:15.590Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01832402" }, { "nct_id": "NCT02107339", "title": "Methadone and Hydromorphone For Spinal Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hydromorphone Use", "Acute Postoperative Pain", "Patient Satisfaction", "Chronic Persistent Surgical Pain" ], "interventions": [ { "name": "Methadone", "type": "DRUG" }, { "name": "Hydromorphone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Endeavor Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 120, "start_date": "2014-03", "completion_date": "2017-09", "has_results": true, "last_update_posted_date": "2019-09-30", "last_synced_at": "2026-10-06T06:11:15.590Z", "location_count": 1, "location_summary": "Evanston, Illinois", "locations": [ { "city": "Evanston", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02107339" }, { "nct_id": "NCT02403830", "title": "Effect of Methylnaltrexone on the PK/PD Profiles of Ticagrelor in Patients Treated With Morphine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "Methylnaltrexone", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Morphine", "type": "DRUG" }, { "name": "Ticagrelor", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 30, "start_date": "2015-08", "completion_date": "2016-05", "has_results": true, "last_update_posted_date": "2017-05-30", "last_synced_at": "2026-10-06T06:11:15.590Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02403830" }, { "nct_id": "NCT01593280", "title": "TAP Catheters Versus Intrathecal Morphine for Cesarean Section", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Abdominal Muscles/Ultrasonography", "Adult", "Anesthetics, Local/Administration & Dosage", "Ropivacaine/Administration & Dosage", "Ropivacaine/Analogs & Derivatives", "Cesarean Section", "Humans", "Nerve Block/Methods", "Pain Measurement/Methods", "Pain, Postoperative/Prevention & Control", "Ultrasonography, Interventional" ], "interventions": [ { "name": "TAP catheter", "type": "DEVICE" }, { "name": "intrathecal morphine", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Stamford Anesthesiology Services, PC", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 80, "start_date": "2012-05", "completion_date": null, "has_results": false, "last_update_posted_date": "2012-05-08", "last_synced_at": "2026-10-06T06:11:15.590Z", "location_count": 1, "location_summary": "Stamford, Connecticut", "locations": [ { "city": "Stamford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01593280" }, { "nct_id": "NCT04813991", "title": "Pain Control Without Opioids", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perioperative Pain" ], "interventions": [ { "name": "Ibuprofen 600 mg", "type": "DRUG" }, { "name": "OxyCODONE 5 Mg Oral Capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hackensack Meridian Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 0, "start_date": "2022-03-15", "completion_date": "2025-09-01", "has_results": false, "last_update_posted_date": "2022-09-10", "last_synced_at": "2026-10-06T06:11:15.590Z", "location_count": 1, "location_summary": "Hackensack, New Jersey", "locations": [ { "city": "Hackensack", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04813991" }, { "nct_id": "NCT01369615", "title": "Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Oxycodone hydrochloride controlled-release tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Purdue Pharma LP", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 23, "start_date": "2011-10", "completion_date": "2014-05", "has_results": true, "last_update_posted_date": "2015-09-09", "last_synced_at": "2026-10-06T06:11:15.590Z", "location_count": 13, "location_summary": "Birmingham, Alabama • Paramount, California • Aurora, Colorado + 10 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Paramount", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Miami", "state": "Florida" }, { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT01369615" }, { "nct_id": "NCT01431326", "title": "Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Adenovirus", "Anesthesia", "Anxiety", "Anxiolysis", "Autism", "Autistic Disorder", "Bacterial Meningitis", "Bacterial Septicemia", "Benzodiazepine", "Bipolar Disorder", "Bone and Joint Infections", "Central Nervous System Infections", "Convulsions", "Cytomegalovirus Retinitis", "Early-onset Schizophrenia Spectrum Disorders", "Epilepsy", "General Anesthesia", "Gynecologic Infections", "Herpes Simplex Virus", "Infantile Hemangioma", "Infection", "Inflammation", "Inflammatory Conditions", "Intra-abdominal Infections", "Lower Respiratory Tract Infections", "Migraines", "Pain", "Pneumonia", "Schizophrenia", "Sedation", "Seizures", "Skeletal Muscle Spasms", "Skin and Skin-structure Infections", "Treatment-resistant Schizophrenia", "Urinary Tract Infections", "Withdrawal", "Sepsis", "Gram-negative Infection", "Bradycardia", "Cardiac Arrest", "Cardiac Arrhythmia", "Staphylococcal Infections", "Nosocomial Pneumonia", "Neuromuscular Blockade", "Methicillin Resistant Staphylococcus Aureus", "Endocarditis", "Neutropenia", "Headache", "Fibrinolytic Bleeding", "Pulmonary Arterial Hypertension", "CMV Retinitis", "Hypertension", "Chronic Kidney Diseases", "Hyperaldosteronism", "Hypokalemia", "Heart Failure", "Hemophilia", "Heavy Menstrual Bleeding", "Insomnia" ], "interventions": [ { "name": "The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daniel Benjamin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 3520, "start_date": "2011-11", "completion_date": "2019-11", "has_results": false, "last_update_posted_date": "2023-09-06", "last_synced_at": "2026-10-06T06:11:15.590Z", "location_count": 43, "location_summary": "Anchorage, Alaska • Little Rock, Arkansas • La Jolla, California + 37 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01431326" }, { "nct_id": "NCT01924182", "title": "Intrathecal Morphine Compared to Conventional Medical Management for Pain Control and Opioid-related Side Effects", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Pain" ], "interventions": [ { "name": "SynchroMed Infusion System and Intrathecal Morphine Sulfate", "type": "DEVICE" }, { "name": "Conventional Medicine", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "MedtronicNeuro", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7, "start_date": "2013-10", "completion_date": "2015-07", "has_results": true, "last_update_posted_date": "2018-03-29", "last_synced_at": "2026-10-06T06:11:15.590Z", "location_count": 6, "location_summary": "Homewood, Alabama • Napa, California • Walnut Creek, California + 3 more", "locations": [ { "city": "Homewood", "state": "Alabama" }, { "city": "Napa", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01924182" } ] }